Literature DB >> 34320205

Utilization of ethanol for itaconic acid biosynthesis by engineered Saccharomyces cerevisiae.

Yaying Xu1, Zhimin Li1,2.   

Abstract

In Saccharomyces cerevisiae, ethanol can serve as both a carbon source and NADH donor for the production of acetyl-CoA derivatives. Here we investigated the metabolic regulation of ethanol utilization for itaconic acid production by S. cerevisiae. To understand the interconnection between the TCA cycle and the glyoxylate pathway, mitochondrial membrane transporter proteins SFC1, YHM2, CTP1, DIC1 and MPC1 were knocked out and results showed that SFC1 functions as an important entrance of the glyoxylate pathway into the TCA cycle, and YHM2 is helpful to IA production but not the primary pathway for citric acid supply. To decrease the accumulation of acetic acid, the major ADP/ATP carrier of the mitochondrial inner membrane, AAC2, was upregulated and determined to accelerate ethanol utilization and itaconic acid production. RNA sequencing results showed that AAC2 overexpression enhanced IA titer by upregulating the ethanol-acetyl-CoA pathway and NADH oxidase in the mitochondrial membrane. RNA-seq analysis also suggested that aconitase ACO1 may be a rate-limiting step of IA production. However, the expression of exogenous aconitase didn't increase IA production but enhanced the rate of ethanol utilization and decreased cell growth.
© The Author(s) 2021. Published by Oxford University Press on behalf of FEMS. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Saccharomyces cerevisiaezzm321990 ; AAC2; acetic acid; ethanol; itaconic acid

Mesh:

Substances:

Year:  2021        PMID: 34320205     DOI: 10.1093/femsyr/foab043

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  1 in total

Review 1.  The Potential of Sequential Fermentations in Converting C1 Substrates to Higher-Value Products.

Authors:  Christina Stark; Sini Münßinger; Frank Rosenau; Bernhard J Eikmanns; Andreas Schwentner
Journal:  Front Microbiol       Date:  2022-06-03       Impact factor: 6.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.